- Eli Lilly Stock Plummets After Earnings Miss. Weight-Loss Drug Sales Fell Short. Barron’s
- Eli Lilly stock tumbles after drug giant misses estimates and slashes profit guidance CNBC
- Lilly reports Q3 2024 financial results highlighted by strong volume-driven revenue growth from New Products Investors | Eli Lilly and Company
- Eli Lilly stock tumbles on Q3 miss from Zepbound shortfall Yahoo Finance
- Eli Lilly’s weight-loss drug misses Wall Street expectations, shares tumble Reuters